Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06905652
PHASE1

Comparative Acute Effects of R-MDMA and S-MDMA in Healthy Participants

Sponsor: University Hospital, Basel, Switzerland

View on ClinicalTrials.gov

Summary

Racemic ±3,4-methylenedioxymethamphetamine (MDMA) is a psychoactive substance and prototypical empathogen acutely inducing feelings of heightened mood, empathy, trust and closeness to others. These acute subjective effects of MDMA may be helpful to assist psychotherapy and MDMA has been investigated in phase 3 trials as a possible treatment in post-traumatic stress disorder.

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2025-07-29

Completion Date

2026-11

Last Updated

2025-07-30

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

R-3,4-methylenedioxymethamphetamine

A dose of 300mg enantiomeric R-MDMA will be administered.

DRUG

S-3,4-methylenedioxymethamphetamine

A dose of 100mg enantiomeric S-MDMA will be administered.

OTHER

Placebo

Placebo (Mannitol)

Locations (1)

University Hospital Basel

Basel, Canton of Basel-City, Switzerland